Dental Membrane and Bone Graft Substitute Market

Global Dental Membrane and Bone Graft Substitute Market Size (2023 to 2028)

The worldwide dental membrane and bone graft substitute market is poised to register a CAGR of 7.7% during the forecast period and the global market size is expected to grow from USD 650 million in 2023 to USD 1014 million by 2028.

Dental membranes and bone grafts are the materials that have gained immense importance in the dental industry. The dental membranes are thin collagen membranes used to protect the newly regenerating bone with the use of a bone graft. The dental membranes prevent any damage to the bone graft material during the bone regeneration process. As the healing process starts, the soft tissues form on the dental membrane and speed up the bone formation processes as the healing is enhanced due to the proper placement of the dental membrane. The dental membranes are mostly made up of collagen membranes or polytetrafluoroethylene (ePTFE).  A bone graft is used in case of bone loss or deformation of bone that has happened due to accidental trauma or natural. It can replace bone and provide the strength required to hold the implants. Bone grafts can be made synthetically, allografts (bone extracts from human cadavers), xenografts (bone extracts derived from animals), and also alloplastic (bone synthetically made of biomaterials).

MARKET DRIVERS:

Nowadays, the number of people considering traveling to foreign countries for better-quality dental treatment is rising, and there has been a rise in dental tourism destinations all over the world. This ultimately results in the increasing demand for the dental membrane and bone graft substitute market share. Developing countries such as Mexico, India, Hungary, and China provide better quality dental treatment at effective prices. Likewise, the dental membrane and bone graft substitute market is expanding in many of the regions that haven’t been penetrated. The increasing number of people opting for dental implants also drives the demand for dental membrane and bone graft substitutes and contributes to the growth of the global market.

The field of implant dentistry has gained popularity in recent years in many countries. According to the World Health Organization (WHO), currently, more than 3.5 billion patients worldwide are suffering from some or other dental condition, which includes oral cancer, gum diseases, dental trauma, or other minor issues. This drives the usage of dental membrane and bone graft substitutes as the usage of the product increases significantly. The dental membrane and bone graft substitute market share is growing rapidly as aesthetics are given immense importance nowadays and dental structure is considered important in many of the fields. Likewise, factors such as growing dental tourism, the rising popularity of implant treatment and other oral disorders, and the importance of aesthetics in the industry are propelling the dental membrane and bone graft substitute market growth.

MARKET RESTRAINTS:

The limited availability of some of the specific kinds of dental implants in some of the regions limits the growth of the dental membrane and bone graft substitute market share as it limits the usage of dental membranes and bone grafts. There are certain complications associated with the use of dental membranes and bone graft substitutes, like infection and inflammation, and it may also happen that the body does not accept the bone graft. It is also important that the patient carries the bone graft and dental membrane till prescribed by the dentist. These risks result in the decreasing growth of the dental membrane and bone graft substitute market. The dental membranes and bone grafts are expensive materials compared to other dental materials used in treatment. This limits the dental membrane and bone graft substitute market share as people with limited financial resources cannot afford these procedures. Hence, limited availability in certain regions, associated complications, and the high cost of treatment are the major factors that limit the growth of the dental membrane and bone graft substitute market growth.

Impact of COVID-19 on the dental membrane and bone graft substitutes market:

The COVID-19 pandemic had a slightly negative impact on the dental membrane and bone graft substitute market, as the dental membrane and bone graft substitute market share is said to have experienced around a 5% decline. The patients had a content fear of contracting the COVID-19 virus in a dental setting. In 2022, as per a report published by the American Board of Dental and Maxillofacial Surgery, the number of people opting for dental implants and bone regenerative procedures has reduced significantly. The global supply chain was disrupted during the COVID-19 pandemic, this resulted in a lack of supply of raw materials required for the manufacturing of bone grafting materials and dental membranes. Also, the delivery of produced dental membranes and bone grafts to dentists and hospitals was not feasible. The dental procedures might not be pocket-friendly for some of the patients and the financial crisis that was being experienced during the COVID-19 pandemic affected it as the scheduled procedures were postponed or canceled.

Though the COVID-19 pandemic had a negative impact on the dental membrane and bone graft substitute market, the dental membrane and bone graft substitute market share grew again in the post-pandemic period as the focus has now shifted to personalized treatment, which appeals to more and more people. Also, new materials that are biocompatible and resorbable are now being used in the production of bone grafts and dental membranes.

REPORT COVERAGE:

This research report on dental membrane and bone graft substitute market segmentation and sub-segmented based on the following categories.

Global Dental Membrane and Bone Graft Substitute Market – By Type:

• Absorbable
• Non-Absorbable
• Autograft
• Allo Graft

The absorbable type is ruling in the dental membrane and bone graft substitute market with a market of around 50%. The absorbable membranes are less likely to cause any kind of complications and also due to their biocompatible nature. The absorbable membranes are used in non-invasive types of surgeries and this segment is gaining popularity among patients. Thus, the usage of absorbable membranes is increasing day by day.

The non-absorbable segment holds second place in the dental membrane and bone graft substitute market with a market share of 20%. A risk of complication is associated with the nonabsorbable membrane. The nonabsorbable membranes are less expensive as compared to absorbable membranes. 

The Allografts are the bone grafts taken from a cadaver and account for 10% of the dental membrane and bone graft substitute market share. These grafts produce better results than the synthetic grafts made in labs.

Auto grafts are bone grafts that are taken from the patient's own body, mostly from the thigh or pelvic region. These are more expensive grafts compared to absorbable ones and also produce the best results. The autografts segment accounts for 10% of the dental membrane and bone graft substitute market share.

Global Dental Membrane and Bone Graft Substitute Market – By Material:

• Hydrogel
• Collagen
• Tricalcium Phosphate

The hydrogel segment is leading the dental membrane and bone graft substitute market with a 35% market share. The hydrogel is a biocompatible material and holds water. Hydrogel can protect the bone graft material and also helps the bone reformation process.

Collagen holds second place in the dental membrane and bone graft substitute market with a market share of 30%. Collagen is a biocompatible as well as biodegradable material, which makes it a good option to be used as a dental membrane as it is a material that is present in the body.

Tricalcium phosphate accounts for 25% of the dental membrane and bone graft substitute market share. It is a synthetic material and is made up of calcium and phosphate ions. Its strength makes it a good option to be used as a dental membrane.

Some other materials like demineralized bone matrix and xenogeneic bone graft substitutes are also used and account for 10% of the dental membrane and bone graft substitute market share.

Global Dental Membrane and Bone Graft Substitute Market – By Region:

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa

The region that is leading the dental membrane and bone graft substitute market is North America, which accounts for around 35% of the market share. The number of patients suffering from oral diseases is rising, which has resulted in an increased demand for dental implants. The United States is the biggest market in the North American region.

The European region accounts for around 25% of the dental membrane and bone graft substitute market share. European countries like Germany, France, Italy, and the UK have shown high expenditure on oral health. Access to advanced technology and modern equipment has resulted in rising demand for dental membrane and bone graft substitutes.

Asia Pacific region accounts for 20% of the dental membrane and bone graft substitute market share. This region has experienced rapid growth in recent years, with a CAGR of 8.5%. The rising population is one of the biggest reasons for the rapid development of the dental health industry in the Asia Pacific region. In countries like India, the number of people considering dental implants is increasing day by day.

Latin America accounts for 10% of the dental membrane and bone graft substitute market share, and countries like Mexico and Brazil are the biggest markets in the region.

The Middle East & Africa region holds 10% of the dental membrane and bone graft substitute market share. South Africa is the biggest market for dental membrane and bone graft substitutes in the region.

KEY MARKET PLAYERS:

The key market players in the dental membrane and bone graft substitute market are Medtronic plc, Straumann Group, LifeNet Health, KLS Martin Group, and Dentsply Sirona.

RECENT MARKET DEVELOPMENTS:

• In February 2022, Orthofix partnered with CGBio to expand in the Asian market for products including spine, orthopedic and dental treatments.
• In February 2022, TheraVet, which specializes in osteoarticular diseases in pets, launched a bone graft product named BIOCERA-VET SmartGraft which can substitute bone.